Lorraine Olson Ramig
Research Subjects
Research Interests
Lorraine Olson Ramig has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Shimon Sapir
4 shared publicationsCynthia Fox
3 shared publicationsStefanie Countryman
Denver, CO
3 shared publicationsMarshall E. Smith
University of Utah Salt Lake City
2 shared publicationsA A Pawlas
1 shared publicationBrad Story
University of Arizona, Tucson, and National Center for Voice and Speech, The Denver Center for the Performing Arts, CO
1 shared publication
Latest Publications
- 1 February 2008
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 8 (2) , 297-309
Speech treatment for Parkinson’s disease
Researchers estimate that 89% of people with Parkinson's disease (PD) have speech and voice disorders including disorders of laryngeal, respiratory and articulatory function. Despite the high incidence of speech and voice impairment, studies suggest that only 3-4% of people with PD receive speech treatment. Here, we review the literature on the characteristics and features of speech and voice disorders in people with PD and the types of treatment techniques available (medical, surgical and behavioral), with a focus on behavioral therapies. We provide a summary of the current status of the field of speech treatment in PD and recommendations for implementation of the current efficacy of treatment interventions. Directions for future research, including a speculative viewpoint on how the field will evolve in 5 years time, are discussed.
- 1 February 2008
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 8 (2) , 297-309
Speech treatment for Parkinson’s disease
Researchers estimate that 89% of people with Parkinson's disease (PD) have speech and voice disorders including disorders of laryngeal, respiratory and articulatory function. Despite the high incidence of speech and voice impairment, studies suggest that only 3-4% of people with PD receive speech treatment. Here, we review the literature on the characteristics and features of speech and voice disorders in people with PD and the types of treatment techniques available (medical, surgical and behavioral), with a focus on behavioral therapies. We provide a summary of the current status of the field of speech treatment in PD and recommendations for implementation of the current efficacy of treatment interventions. Directions for future research, including a speculative viewpoint on how the field will evolve in 5 years time, are discussed.
- 7 May 2004
- Published by Georg Thieme Verlag KG in Seminars in Speech and Language
- Vol. 25 (02) , 169-180
Parkinson's Disease: Speech and Voice Disorders and Their Treatment with the Lee Silverman Voice Treatment
Speech and voice disorders are very common among individuals suffering from idiopathic Parkinson's disease. In this article we review evidence for laryngeal, respiratory, articulatory, and velopharyngeal disorders in this population. We present the essential concepts and outcome data for the Lee Silverman Voice Treatment®, a behavioral treatment program that has yielded significant long-term improvement in speech and voice functions in individuals with idiopathic Parkinson's disease.
- 7 May 2004
- Published by Georg Thieme Verlag KG in Seminars in Speech and Language
- Vol. 25 (02) , 169-180
Parkinson's Disease: Speech and Voice Disorders and Their Treatment with the Lee Silverman Voice Treatment
Speech and voice disorders are very common among individuals suffering from idiopathic Parkinson's disease. In this article we review evidence for laryngeal, respiratory, articulatory, and velopharyngeal disorders in this population. We present the essential concepts and outcome data for the Lee Silverman Voice Treatment®, a behavioral treatment program that has yielded significant long-term improvement in speech and voice functions in individuals with idiopathic Parkinson's disease.
- 1 November 2003
- Published by American Speech Language Hearing Association in American Journal of Speech-Language Pathology
- Vol. 12 (4) , 387-399
Effects of Intensive Voice Treatment (the Lee Silverman Voice Treatment [LSVT]) on Ataxic Dysarthria
This study examined the effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT®]) on ataxic dysarthria in a woman with cerebellar dysfunction secondary to thiamine deficiency. Perceptual and acoustic measures were made on speech samples recorded just before the LSVT program was administered, immediately after it was administered, and at 9 months follow-up. Results indicate short- and long-term improvement in phonatory and articulatory functions, speech intelligibility, and overall communication and job-related activity following LSVT. This study’s findings provide initial support for the application of LSVT to the treatment of speech disorders accompanying ataxic dysarthria. Potential neural mechanisms that may underlie the effects of loud phonation and LSVT are addressed.
- 1 November 2003
- Published by American Speech Language Hearing Association in American Journal of Speech-Language Pathology
- Vol. 12 (4) , 387-399
Effects of Intensive Voice Treatment (the Lee Silverman Voice Treatment [LSVT]) on Ataxic Dysarthria
This study examined the effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT®]) on ataxic dysarthria in a woman with cerebellar dysfunction secondary to thiamine deficiency. Perceptual and acoustic measures were made on speech samples recorded just before the LSVT program was administered, immediately after it was administered, and at 9 months follow-up. Results indicate short- and long-term improvement in phonatory and articulatory functions, speech intelligibility, and overall communication and job-related activity following LSVT. This study’s findings provide initial support for the application of LSVT to the treatment of speech disorders accompanying ataxic dysarthria. Potential neural mechanisms that may underlie the effects of loud phonation and LSVT are addressed.
- 1 April 2002
- Published by American Speech Language Hearing Association in The ASHA Leader
- Vol. 7 (8) , 6-19
The Joy of Research
“I don’t want to be a researcher, I want to help people.” How many times have I heard those words spoken by one of my master’s degree students? Why is it, I ask myself, that the research world, which brings so much joy to so many of us, is often perceived by our students as existing in a realm totally removed from anything practical? Since research doesn’t directly help people, some of our students wonder—why should I pursue it?
- 1 April 2002
- Published by American Speech Language Hearing Association in The ASHA Leader
- Vol. 7 (8) , 6-19
The Joy of Research
“I don’t want to be a researcher, I want to help people.” How many times have I heard those words spoken by one of my master’s degree students? Why is it, I ask myself, that the research world, which brings so much joy to so many of us, is often perceived by our students as existing in a realm totally removed from anything practical? Since research doesn’t directly help people, some of our students wonder—why should I pursue it?
- Top Cited PapersOpen Access
- 1 October 2001
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 71 (4) , 493-498
Intensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow up
OBJECTIVES To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT®), a method designed to improve vocal function in patients with Parkinson's disease. METHODS Thirty three patients with idiopathic Parkinson's disease were stratified and randomly assigned to two treatment groups. One group received the LSVT®, which emphasises high phonatory-respiratory effort. The other group received respiratory therapy (RET), which emphasises high respiratory effort alone. Patients in both treatment groups sustained vowel phonation, read a passage, and produced a monologue under identical conditions before, immediately after, and 24 months after speech treatment. Change in vocal function was measured by means of acoustic analyses of voice loudness (measured as sound pressure level, or SPL) and inflection in voice fundamental frequency (measured in terms of semitone standard deviation, or STSD). RESULTS The LSVT® was significantly more effective than the RET in improving (increasing) SPL and STSD immediately post-treatment and maintaining those improvements at 2 year follow up. CONCLUSIONS The findings provide evidence for the efficacy of the LSVT® as well as the long term maintenance of these effects in the treatment of voice and speech disorders in patients with idiopathic Parkinson's disease.
- 1 October 2001
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 71 (4) , 493-498
Top Cited PapersOpen AccessIntensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow up
OBJECTIVES To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT®), a method designed to improve vocal function in patients with Parkinson's disease. METHODS Thirty three patients with idiopathic Parkinson's disease were stratified and randomly assigned to two treatment groups. One group received the LSVT®, which emphasises high phonatory-respiratory effort. The other group received respiratory therapy (RET), which emphasises high respiratory effort alone. Patients in both treatment groups sustained vowel phonation, read a passage, and produced a monologue under identical conditions before, immediately after, and 24 months after speech treatment. Change in vocal function was measured by means of acoustic analyses of voice loudness (measured as sound pressure level, or SPL) and inflection in voice fundamental frequency (measured in terms of semitone standard deviation, or STSD). RESULTS The LSVT® was significantly more effective than the RET in improving (increasing) SPL and STSD immediately post-treatment and maintaining those improvements at 2 year follow up. CONCLUSIONS The findings provide evidence for the efficacy of the LSVT® as well as the long term maintenance of these effects in the treatment of voice and speech disorders in patients with idiopathic Parkinson's disease.
- 1 April 2001
- Published by American Speech Language Hearing Association in Journal of Speech, Language, and Hearing Research
- Vol. 44 (2) , 297-305
Control of Vocal Loudness in Young and Old Adults
This study examined the effect of aging on respiratory and laryngeal mechanisms involved in vocal loudness control. Simultaneous measures of subglottal pressure and electromyographic (EMG) activity from the thyroarytenoid (TA), lateral cricoarytenoid (LCA), and cricothyroid (CT) muscles were investigated in young and old individuals while they attempted to phonate at three loudness levels, "soft," "comfortable," and "loud." Voice sound pressure level (SPL) and fundamental frequency (F0) measures were also obtained. Across loudness conditions, subglottal pressure levels were similar for both age groups. Laryngeal EMG measures tended to be lower and more variable for old compared with young individuals. These differences were most apparent for the TA muscle. Finally, across the three loudness conditions, the old individuals generated SPLs that were lower overall than those produced by the young individuals but modulated loudness levels in a manner similar to that of the young subjects. These findings suggest that the laryngeal mechanism may be more affected than the respiratory system in these old individuals and that these changes may affect vocal loudness levels.
- 1 April 2001
- Published by American Speech Language Hearing Association in Journal of Speech, Language, and Hearing Research
- Vol. 44 (2) , 297-305
Control of Vocal Loudness in Young and Old Adults
This study examined the effect of aging on respiratory and laryngeal mechanisms involved in vocal loudness control. Simultaneous measures of subglottal pressure and electromyographic (EMG) activity from the thyroarytenoid (TA), lateral cricoarytenoid (LCA), and cricothyroid (CT) muscles were investigated in young and old individuals while they attempted to phonate at three loudness levels, "soft," "comfortable," and "loud." Voice sound pressure level (SPL) and fundamental frequency (F0) measures were also obtained. Across loudness conditions, subglottal pressure levels were similar for both age groups. Laryngeal EMG measures tended to be lower and more variable for old compared with young individuals. These differences were most apparent for the TA muscle. Finally, across the three loudness conditions, the old individuals generated SPLs that were lower overall than those produced by the young individuals but modulated loudness levels in a manner similar to that of the young subjects. These findings suggest that the laryngeal mechanism may be more affected than the respiratory system in these old individuals and that these changes may affect vocal loudness levels.
- Open Access
- 1 November 1997
- Published by American Speech Language Hearing Association in American Journal of Speech-Language Pathology
- Vol. 6 (4) , 74-84
Supraglottal Hyperadduction in an Individual With Parkinson Disease
Recent treatment for voice problems associated with idiopathic Parkinson disease has primarily focused on increasing reduced vocal loudness and improving true vocal fold hypoadduction, common voice deficits observed in these individuals. This study presents an individual with reduced vocal loudness and supraglottic hyperadduction accompanying Parkinson disease and the outcome following a course of the Lee Silverman Voice Treatment (LSVT). Posttreatment observations included increased vocal loudness, decreased supraglottic hyperadduction, and improved intonation and overall voice quality when compared with pretreatment observations. These results suggest that in this individual, supraglottic hyperadduction was due to a secondary compensatory behavior resulting from mild true vocal fold hypoadduction that responded positively to adduction therapy (LSVT). This study also demonstrates the use of a continuum of observations ranging from functional ratings to physiological measures to evaluate the impact of intensive voice treatment and identify mechanisms underlying treatment-related change in an individual with Parkinson disease.
- 1 November 1997
- Published by American Speech Language Hearing Association in American Journal of Speech-Language Pathology
- Vol. 6 (4) , 74-84
Open AccessSupraglottal Hyperadduction in an Individual With Parkinson Disease
Recent treatment for voice problems associated with idiopathic Parkinson disease has primarily focused on increasing reduced vocal loudness and improving true vocal fold hypoadduction, common voice deficits observed in these individuals. This study presents an individual with reduced vocal loudness and supraglottic hyperadduction accompanying Parkinson disease and the outcome following a course of the Lee Silverman Voice Treatment (LSVT). Posttreatment observations included increased vocal loudness, decreased supraglottic hyperadduction, and improved intonation and overall voice quality when compared with pretreatment observations. These results suggest that in this individual, supraglottic hyperadduction was due to a secondary compensatory behavior resulting from mild true vocal fold hypoadduction that responded positively to adduction therapy (LSVT). This study also demonstrates the use of a continuum of observations ranging from functional ratings to physiological measures to evaluate the impact of intensive voice treatment and identify mechanisms underlying treatment-related change in an individual with Parkinson disease.
- 1 January 1997
- Vol. 39 (1) , 34-5
How effective is the Lee Silverman voice treatment?
- 1 October 1996
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 100 (4_Suppleme) , 2662
Treatment for the aging voice: Acoustic, aerodynamic, and electromyographic changes
- 1 October 1996
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 100 (4_Suppleme) , 2662
Treatment for the aging voice: Acoustic, aerodynamic, and electromyographic changes
- Open Access
- 1 August 1996
- Published by American Speech Language Hearing Association in Journal of Speech, Language, and Hearing Research
- Vol. 39 (4) , 798-807
Aerodynamic Mechanisms Underlying Treatment-Related Changes in Vocal Intensity in Patients With Parkinson Disease
The purpose of this study was to document changes in aerodynamic and glottographic aspects of vocal function in patients with Parkinson disease who received two forms of high effort treatment. Previous reports (Ramig, Countryman, Thompson, & Horii, 1995) have documented increased sound pressure level (SPL) following treatment that trained phonation and respiration (Lee Silverman Voice Treatment: LSVT), but not for treatment that trained respiration only (R). In order to examine the mechanisms underlying these differences, measures of maximum flow declination rate (MFDR) and estimated subglottal pressure (Psub) were made before and after treatment. A measure of relative vocal fold adduction (EGGW) was made from the electroglottographic signal during sustained vowel phonation. Sound pressure level data from syllable repetition, sustained vowel phonation, reading, and monologue tasks were also analyzed to allow a more detailed understanding of treatment-related change in several contexts. Consistent with increases in SPL, significant increases in MFDR, estimated Psub, and EGGW were measured posttreatment in patients who received the LSVT. Similar changes were not observed following R treatment. These findings suggest that the combination of increased vocal fold adduction and subglottal pressure is a key in generating posttreatment increases in vocal intensity in idiopathic Parkinson disease (IPD).
- 1 August 1996
- Published by American Speech Language Hearing Association in Journal of Speech, Language, and Hearing Research
- Vol. 39 (4) , 798-807
Open AccessAerodynamic Mechanisms Underlying Treatment-Related Changes in Vocal Intensity in Patients With Parkinson Disease
The purpose of this study was to document changes in aerodynamic and glottographic aspects of vocal function in patients with Parkinson disease who received two forms of high effort treatment. Previous reports (Ramig, Countryman, Thompson, & Horii, 1995) have documented increased sound pressure level (SPL) following treatment that trained phonation and respiration (Lee Silverman Voice Treatment: LSVT), but not for treatment that trained respiration only (R). In order to examine the mechanisms underlying these differences, measures of maximum flow declination rate (MFDR) and estimated subglottal pressure (Psub) were made before and after treatment. A measure of relative vocal fold adduction (EGGW) was made from the electroglottographic signal during sustained vowel phonation. Sound pressure level data from syllable repetition, sustained vowel phonation, reading, and monologue tasks were also analyzed to allow a more detailed understanding of treatment-related change in several contexts. Consistent with increases in SPL, significant increases in MFDR, estimated Psub, and EGGW were measured posttreatment in patients who received the LSVT. Similar changes were not observed following R treatment. These findings suggest that the combination of increased vocal fold adduction and subglottal pressure is a key in generating posttreatment increases in vocal intensity in idiopathic Parkinson disease (IPD).